Navigation Links
The Biotechnology Industry Organization and Critical Path Institute Partner With Mediaplanet, Biocom, and the University of California Office to Spotlight the Science That Is Healing, Fueling and Feeding Our Global Population
Date:12/9/2010

LOS ANGELES, Dec. 9, 2010 /PRNewswire/ -- On Thursday, December 9th, Mediaplanet published one of the largest consumer reports on biotechnology, spearheading an industry-wide call to action advocating consumer support of biotechnology, the science that is helping us confront society's most pressing challenges. By teaming up with the world's largest biotechnology organization, Mediaplanet's 'Biotechnology' encourages appropriate policy action and investment in the science that is healing, fueling and feeding our future. Biotechnology is the medical discovery that saves millions of lives, the agricultural innovation that fends off impending world hunger and the solution to ever-rising crude oil prices. The crucial idea—that investment in biotechnology is an investment in our future and in essence, in ourselves—is the idea this report aims to bring home.

(Logo:  http://photos.prnewswire.com/prnh/20100820/CG52983LOGO)

Rolf Benirschke Dedicates Life After Ulcerative Colitis to Biomedical Advancements

"I've been a beneficiary of modern science based on research," explains former San Diego Charger and NFL Great, Rolf Benirschke, on his struggle with ulcerative colitis, and the blood transfusion that both saved his life and gave him Hepatitis C. Son of a world-renowned pathologist, Benirschke finds himself in the medical field dealing with biotechnology advancements on a daily basis.

No on Proposition 23: California Biofuels Industry Poised for Growth

During the November elections, Proposition 23 was defeated by California voters—California is poised to take the lead in clean and renewable energy, with emerging solutions like algae based biofuels, and large-scale production of advanced biofuels.

James C. Greenwood Explains Regulatory Approval Process for Biosimilars

An important provision of healthcare reform established a regulatory approval process for biosimilars, medicines that are similar to pioneering biologics. BIO encourages the FDA to make patient safety the priority, while preserving necessary incentives to develop new breakthrough therapies.

Mediaplanet's Report:

With the help of the Biotechnology Industry Organization, Critical Path Institute, Biocom, the University of California Office of the President, Algenol, Amgen, Byogy, EquipNet, and Syngenta, Mediaplanet published one of the largest distributed Biotechnology report in US history.

To view this report CLICK HERE or click the link below: http://www.latimesinteractive.com/advertising/mediaplanet/biotechnology/images/LaT%20Biotechnology%20FINAL%20smO.PDF

Mediaplanet creates focused reports on business, healthcare and technology.

For more information go to www.mediaplanet.com or call 312-337-4000.


'/>"/>
SOURCE Mediaplanet
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
2. Yongye Biotechnology International Retains CCG Investor Relations
3. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
4. Yongye Biotechnology International Announces Second Quarter Results
5. BeaconEquity.com Issues Trade Alerts on Biotechnology Stocks: ELN, PFE, AMGN, DNA, BIIB, GILD
6. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
7. DuPont Obtains Biotechnology Endorsement for Pioneer(R) Brand Products
8. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
10. InNexus Biotechnology CEO to Present at The Wall Street Analyst Forum in NYC
11. InNexus Biotechnology Strengthens Patent Team With New Leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook Labs is ... include an array of biochemical analyses critical for Lead Discovery. The company’s ... and SAR programs, including inhibitor potency and selectivity, mechanism of action, and inhibitor ...
(Date:2/23/2017)... 23, 2017  MIODx announced today that it ... immunotherapy technologies from the University of California, San ... to monitor a patient for response to immune ... The second license extends the technology with a ... to have an immune-related adverse event (IRAE) from ...
(Date:2/23/2017)... 23, 2017  Seattle,s upscale Capitol Hill neighborhood, with its swanky ... for a head lice treatment salon to set up shop. ... restaurant and a French bistro on E Madison Ave, and ... just any old lice clinic, we pride ourselves on being ... release some of the stigma associated with lice. Everyone can ...
(Date:2/23/2017)... ... February 23, 2017 , ... Brain Sentinel, ... begin marketing the SPEAC® System, the Brain Sentinel® Seizure Monitoring and Alerting System. ... healthcare facilities during periods of rest. A lightweight, non-invasive monitor is placed on ...
Breaking Biology Technology:
(Date:1/24/2017)... PHILADELPHIA , Jan. 24, 2017  It ... a baby,s sock that monitors vital signs and ... instance, an infant,s oxygen saturation level drops. But ... undue alarm to parents, with no evidence of ... "These devices are marketed aggressively to parents of ...
(Date:1/19/2017)... India , January 19, 2017 According to a ... Opportunities and Forecast, 2014 - 2022," the global biometric sensor market is expected ... 2016 to 2022. In 2015, Asia-Pacific dominated the global ... and private sectors. Continue Reading ... ...
(Date:1/18/2017)... 2017 MedNet Solutions , an ... entire spectrum of clinical research, is proud to ... for the organization in terms of corporate growth, ... products and services. The company,s exceptional achievements can ... iMedNet ™ – ...
Breaking Biology News(10 mins):